11 completed. 11 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 11 | Completed 11 |
Follow Hemostatic Disorders: new trials by email Literature Review of Hemostatic Disorders trials Research Report on Hemostatic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects NEX-20A - Multiple Myeloma | Early Phase 1 | Completed | Nanexa AB | 9 | 2022-11-28 | 2023-10-31 |
| Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors Shingrix vaccine - Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) | Early Phase 1 | Completed | University of Rochester | 33 | 2019-02-01 | 2024-03-15 |
| Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor T cell infusion agent targeting BCMA chimeric antigen receptor - Multiple Myeloma | Early Phase 1 | Completed | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 3 | 2018-10-11 | 2020-12-03 |
| Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) Survivin Vaccine, Autologous Hematopoietic Cell Transplantation, Prevnar 13 - Multiple Myeloma | Early Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 14 | 2016-09-27 | 2022-11-14 |
| Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Dynamic contrast-enhanced computed tomography, Ioversol - Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | Early Phase 1 | Completed | Washington University School of Medicine | 21 | 2014-06-01 | 2015-06-11 |
| Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant busulfan, etoposide, cyclophosphamide - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 33 | 2014-03-01 | 2015-08-13 |
| Autophagy Induction After Bortezomib for Myeloma Bortezomib - Multiple Myeloma | Early Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 11 | 2012-07-10 | 2019-04-16 |
| Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT Eltrombopag - Multiple Myeloma | Early Phase 1 | Completed | Dana-Farber Cancer Institute | 19 | 2011-03-01 | 2019-03-01 |
| Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases Pemetrexed - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders | Early Phase 1 | Completed | Northwestern University | 15 | 2007-01-01 | 2021-09-08 |
| Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation Ondansetron, Dexamethasone, Aprepitant - Nausea, Vomiting | Early Phase 1 | Completed | Washington University School of Medicine | 48 | 2005-10-01 | 2013-05-24 |
| Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma rituximab, cyclophosphamide, filgrastim - Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma | Early Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2001-04-01 | 2013-01-09 |
Multiple Myeloma (8) · Leukemia, Lymphocytic, Chronic, B-Cell (4) · Waldenstrom Macroglobulinemia (4) · Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Follicular (3) · Lymphoma, Large B-Cell, Diffuse (3) · Lymphoma, Mantle-Cell (3) · Lymphoma, Non-Hodgkin (3) · Burkitt Lymphoma (2) · Hodgkin Disease (2) · Immunoblastic Lymphadenopathy (2) · Intraocular Lymphoma (2) · Leukemia, Hairy Cell (2) · Leukemia, Large Granular Lymphocytic (2) · Leukemia, Myeloid, Acute (2)
Blood Protein Disorders (11) · Cardiovascular Diseases (11) · Hematologic Diseases (11) · Hemic and Lymphatic Diseases (11) · Hemorrhagic Disorders (11) · Immune System Diseases (11) · Immunoproliferative Disorders (11) · Neoplasms (11) · Neoplasms by Histologic Type (11) · Paraproteinemias (11) · Vascular Diseases (11) · Lymphoproliferative Disorders (10) · Neoplasms, Plasma Cell (9) · Pathological Conditions, Signs and Symptoms (6)
Cyclophosphamide (2) · Granulocyte Colony-Stimulating Factor (2) · Peripheral Blood Stem Cell Transplantation (2) · 13-valent pneumococcal vaccine (1) · Aprepitant (1) · Bortezomib (1) · Busulfan (1) · Contrast Media (1) · Dexamethasone (1) · Etoposide (1) · Filgrastim (1) · Ondansetron (1) · Pemetrexed (1) · Rituximab (1) · eltrombopag (1)
Washington University School of Medicine (2) · Abramson Cancer Center at Penn Medicine (1) · Case Comprehensive Cancer Center (1) · Dana-Farber Cancer Institute (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Nanexa AB (1) · National Cancer Institute (NCI) (1) · Northwestern University (1) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1) · University of Rochester (1)
United States (9) · China (1) · Sweden (1)
Amanda Cashen, M.D. (1) · Brian Hill, MD (1) · Dan Vogl, MD (1) · Frederick Locke, M.D. (1) · Hjalmar Flygt (1) · Jeffrey J. Raizer, MD (1) · John F DiPersio, M.D., Ph.D. (1) · Jonathan Friedberg, MD (1) · Lode Swinnen (1) · Nancy Berliner, MD (1)
P30CA043703 (1)